Navidea Biopharmaceuticals Inc (NAVB) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Navidea Biopharmaceuticals Inc   (NAVB)
 

Navidea Biopharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Navidea Biopharmaceuticals Inc has not recorded any inventories.
Visit Navidea Biopharmaceuticals Inc Balance sheet

Within Healthcare sector 295 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 1444, from total ranking in the second quarter 2023 at 1514.

NAVB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Navidea Biopharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAVB Inventory Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Inventory Growth 137.74 % 45.96 % 42.62 % 182.72 % 8.31 %
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) - - - 0.01 0.01
NAVB's Total Ranking # 1444 # 1514 # 1750 # 2075 # 0
Average inventory processing period - - - 59226 47116
Seq. Inventory Growth 0 % 0.02 % 7.79 % 120.5 % -38.6 %
Seq. Cost of Sales Growth - - - -97.49 % 202.75 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 9
Healthcare Sector # 296
Overall Market # 1444

Inventory Turnover Ratio Statistics
High Average Low
3.24 1.25 0
(Sep 30 2016)   (Sep 30 2021)



NAVB Company Profile >> Back to NAVB Efficiency Comparisons >> Compare NAVB Inventory Turnover Ratio to its Competitors

Financial Statements
Navidea Biopharmaceuticals Inc 's Inventories $ 0 Millions Visit NAVB's Balance sheet
Navidea Biopharmaceuticals Inc 's Cost of Revenues TTM $ 0 Millions Visit NAVB's Income Statement
What are NAVB's Sales? Visit NAVB's Sales by Segment

Other Inventory Turnover Ratios
Navidea Biopharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NAVB's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NAVB's Competitors
Inventory Turnover Ratio for NAVB's Suppliers
Inventory Turnover Ratio for NAVB's Customers

You may also want to know
NAVB's Sales Growth Rates NAVB's Pe Price to earnings ratio NAVB's Receivables Turnover Ratio NAVB's Stock Quote
NAVB's Net Income Growth Rates NAVB's Ps Price to Sales ratio NAVB's Sales per Employee NAVB's Asset Turnover Ratio
NAVB's Net Margin NAVB's Pb Price to Book ratio NAVB's Financial Strength Ratios NAVB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Navidea Biopharmaceuticals Inc 0.00 $ 0.000  Millions$ 0  Millions

Date modified: 2026-08-29T17:28:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.